Florida Senate - 2023                                     SB 754
       
       
        
       By Senator Calatayud
       
       
       
       
       
       38-01828A-23                                           2023754__
    1                        A bill to be entitled                      
    2         An act relating to intravenous vitamin treatment;
    3         providing a short title; creating s. 464.0124, F.S.;
    4         defining the term “intravenous vitamin treatment”;
    5         requiring the Board of Nursing to adopt rules
    6         establishing procedures for administering intravenous
    7         vitamin treatment and establishing related emergency
    8         protocols; providing requirements for such rules;
    9         providing requirements for persons administering
   10         intravenous vitamin treatment to new clients and
   11         certain returning clients; requiring such persons to
   12         obtain a certain assessment from the client before
   13         administering such treatment; prohibiting the
   14         administration of such treatment if the assessment
   15         indicates that it is unsafe for the client; requiring
   16         that clients be provided certain information before
   17         the treatment is administered; requiring persons
   18         administering such treatment to have a written
   19         emergency plan; requiring a copy of the plan be kept
   20         at the location offering such treatment; providing
   21         requirements for the plan; providing an effective
   22         date.
   23          
   24  Be It Enacted by the Legislature of the State of Florida:
   25  
   26         Section 1. This act may be cited as the “Stephanie Balais
   27  Act.”
   28         Section 2. Section 464.0124, Florida Statutes, is created
   29  to read:
   30         464.0124 Administering intravenous vitamin treatment.—
   31         (1) As used in this section, the term “intravenous vitamin
   32  treatment” means a procedure in which high concentrations of
   33  vitamins and minerals are administered directly into a person’s
   34  bloodstream, allowing more rapid absorption of higher doses of
   35  the vitamins and minerals than if received through food or
   36  supplements.
   37         (2) The board shall adopt rules establishing procedures for
   38  safely administering intravenous vitamin treatment and
   39  establishing protocols to follow in the event of an emergency
   40  that would place the life or health of a recipient of such
   41  treatment in danger. The rules must include requirements for all
   42  of the following:
   43         (a) Education and training requirements to administer
   44  intravenous vitamin treatment.
   45         (b) Self-screening risk assessments.
   46         (c) Information that a person administering intravenous
   47  vitamin treatment must provide to a client before administering
   48  such treatment.
   49         (d) Documentation regarding the process of administering
   50  intravenous vitamin treatment.
   51         (e) Notification that must be provided to a client’s
   52  designated physician that an intravenous vitamin treatment was
   53  administered.
   54         (f) Evaluation and review of the administration practices
   55  used to administer intravenous vitamin treatment.
   56         (3) For a new client requesting intravenous vitamin
   57  treatment, and at least every 6 months for each returning
   58  client, a person administering intravenous vitamin treatment
   59  must do all of the following:
   60         (a) Obtain a complete self-screening risk assessment from
   61  the client.
   62         (b) Perform a client assessment.
   63         (c) Provide the client with a visit summary.
   64         (d) Advise the client to seek medical help in case of an
   65  emergency.
   66         (4) A person administering intravenous vitamin treatment
   67  shall:
   68         (a) Obtain a complete self-screening risk assessment
   69  questionnaire that has been approved by the board from the
   70  client before administering intravenous vitamin treatment. If
   71  the results of the assessment indicate that it is unsafe to
   72  administer intravenous vitamin treatment to the client, the
   73  treatment may not be administered.
   74         (b) Provide the client with the following information:
   75         1. Any potential side effects and risks of intravenous
   76  vitamin treatment.
   77         2. Instructions on when to seek medical attention.
   78         (c) Have a written plan for the appropriate provision of
   79  emergency care. A copy of the emergency plan must be kept at the
   80  location offering intravenous vitamin treatment. The plan must
   81  include all of the following:
   82         1. The name and address of the hospital closest to the
   83  location at which the intravenous vitamin treatment is being
   84  performed.
   85         2. Reasons for which an emergency transfer of a client may
   86  be required.
   87         3. Medical services to be used in the event of an emergency
   88  that would place the life or health of a client in danger.
   89         Section 3. This act shall take effect July 1, 2023.